Search research articles
Contact Us
Filters
Showing results (241-250 of 288) with videos related to
Page
of 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria
C S Ha, V Kavadi, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia
M A Dimopoulos, G Hamilos, K Zervas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2007
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
P A Kosmidis, H P Kalofonos, C Christodoulou, et al.
Blood Cancer Journal
|
October 8, 2016
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma
E Terpos, D Christoulas, E Kastritis, et al.
Leukemia
|
February 20, 2009
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)
E Kastritis, K Zervas, A Symeonidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, P I Croucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents
M A Dimopoulos, S Delimpasi, E Katodritou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, C Papadimitriou, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2010
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)
P A Kosmidis, G Fountzilas, A G Eleftheraki, et al.
British Journal of Cancer
|
June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
A Bamias, K Tzannis, B Beuselinck, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 288) with videos related to
Sort By:
Page
of 29
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria
C S Ha, V Kavadi, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia
M A Dimopoulos, G Hamilos, K Zervas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2007
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
P A Kosmidis, H P Kalofonos, C Christodoulou, et al.
Blood Cancer Journal
|
October 8, 2016
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma
E Terpos, D Christoulas, E Kastritis, et al.
Leukemia
|
February 20, 2009
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)
E Kastritis, K Zervas, A Symeonidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, P I Croucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents
M A Dimopoulos, S Delimpasi, E Katodritou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, C Papadimitriou, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2010
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)
P A Kosmidis, G Fountzilas, A G Eleftheraki, et al.
British Journal of Cancer
|
June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
A Bamias, K Tzannis, B Beuselinck, et al.
Page
of 29